KREBS BIOCHEMICALS & INDUSTRIES
|
The Current P/S Ratio of KREBS BIOCHEMICALS & INDUSTRIES is 4.39.
Share Price | ₹100.0 | Feb 05,2025 |
Market Cap | ₹216.0 Cr | |
Sales-TTM | ₹49.2 Cr | TTM-Standalone Results |
Price/Sales | 4.39x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of KREBS BIOCHEMICALS & INDUSTRIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹216.0 Cr] as on Feb 05,2025
(/) Sales [ ₹49.2 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 4.39x ]
Thus, for KREBS BIOCHEMICALS & INDUSTRIES , the investors are currently willing to pay '4.39 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of KREBS BIOCHEMICALS & INDUSTRIES !
The chart below summarizes the trend in P/S Ratio of KREBS BIOCHEMICALS & INDUSTRIES over the last five years.
Historical PS (Price/Sales) ratio chart of KREBS BIOCHEMICALS & INDUSTRIES
PS Ratio Performance Analysis for KREBS BIOCHEMICALS & INDUSTRIES
- KREBS BIOCHEMICALS & INDUSTRIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 3.56x.
- KREBS BIOCHEMICALS & INDUSTRIES 's operated at median p/e ratio of 3.25x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, KREBS BIOCHEMICALS & INDUSTRIES 's p/e ratio peaked in Mar2022 at 5.18x.
- KREBS BIOCHEMICALS & INDUSTRIES 's p/e ratio hit its five-year low in Mar2023 of 2.33x.
How does KREBS BIOCHEMICALS & INDUSTRIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
KREBS BIOCHEMICALS & INDUSTRIES | 49.2 | 4.39 | 216.0 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 51,602.5 | 8.15 | 420,699.0 |
CIPLA LTD | 26,981.2 | 4.30 | 116,022.0 |
DR REDDYS LABORATORIES LTD | 31,229.3 | 3.28 | 102,463.0 |
ZYDUS LIFESCIENCES LTD | 22,247.4 | 4.42 | 98,434.8 |
DIVIS LABORATORIES LTD | 9,078.0 | 17.91 | 162,584.0 |
MANKIND PHARMA LTD | 11,641.0 | 8.80 | 102,447.0 |
TORRENT PHARMACEUTICALS LTD | 11,302.0 | 9.33 | 105,449.0 |
LUPIN LTD | 21,431.3 | 4.66 | 99,816.4 |
AUROBINDO PHARMA LTD | 30,295.0 | 2.28 | 69,222.8 |
ABBOTT INDIA LTD | 6,243.2 | 9.46 | 59,040.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs KREBS BIOCHEMICALS & INDUSTRIES 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.28x |
Max industry PS | 17.91x |
Median industry PS | 4.66x |
Average industry PS | 7.00x |
You may also like the below Video Courses